Baidu
map

带你熟悉--专利申请号

2015-03-18 MedSci MedSci原创

专利申请号 是指国家知识产权局受理一件专利申请时给予该专利申请的一个标识号码。 特点 一个专利申请号只可能用于一件专利申请,即使在一件专利申请或由此取得的专利权灭失之后,任何其他专利申请也不再可能使用该专利申请号。 专利申请号的组成 包括申请年号、申请种类号、申请流水号三个部分。 校验位:是1位阿拉伯数字(0至9)或大写英文字母X。 校验位位于专利申请号之后,在专利申请号与校验位之间

专利申请号


是指国家知识产权局受理一件专利申请时给予该专利申请的一个标识号码。

特点

一个专利申请号只可能用于一件专利申请,即使在一件专利申请或由此取得的专利权灭失之后,任何其他专利申请也不再可能使用该专利申请号。

专利申请号的组成

包括申请年号、申请种类号、申请流水号三个部分。
校验位:是1位阿拉伯数字(0至9)或大写英文字母X。
校验位位于专利申请号之后,在专利申请号与校验位之间使用一个下标单字节实心圆点符号作为间隔符。

申请种类号

1  表示发明专利申请;
2  表示实用新型专利申请;
3  表示外观设计专利申请;
8  表示进入中国国家阶段的PCT发明专利申请;
9  表示进入中国国家阶段的PCT实用新型专利申请;

2003年10月1日之前

专利申请号由9位组成

申请年号(第1-2位)+申请种类号(第3位)+流水号(第4-8位)+X(校验位)

示例:


2003年10月1日之后

专利申请号由13位组成

申请年号(第1-4位)+申请种类号(第5位)+流水号(第6-12位)+X(校验位)

示例1:

示例2:

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=56324, encodeId=3f3156324ff, content=继续加油吧,, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:42:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56325, encodeId=2d635632589, content=继续加油吧,, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:42:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56326, encodeId=2780563260a, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:42:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56322, encodeId=77ae56322ab, content=还是不熟悉,哈哈…, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:41:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56323, encodeId=8626563234b, content=还是不熟悉,哈哈…, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:41:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1704905, encodeId=ca551e04905e7, content=<a href='/topic/show?id=71742062668' target=_blank style='color:#2F92EE;'>#专利申请#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20626, encryptionId=71742062668, topicName=专利申请)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e7a30885975, createdName=zhangjingnwpu, createdTime=Sat Aug 08 01:14:00 CST 2015, time=2015-08-08, status=1, ipAttribution=)]
    2016-01-12 medsic

    继续加油吧,

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=56324, encodeId=3f3156324ff, content=继续加油吧,, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:42:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56325, encodeId=2d635632589, content=继续加油吧,, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:42:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56326, encodeId=2780563260a, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:42:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56322, encodeId=77ae56322ab, content=还是不熟悉,哈哈…, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:41:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56323, encodeId=8626563234b, content=还是不熟悉,哈哈…, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:41:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1704905, encodeId=ca551e04905e7, content=<a href='/topic/show?id=71742062668' target=_blank style='color:#2F92EE;'>#专利申请#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20626, encryptionId=71742062668, topicName=专利申请)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e7a30885975, createdName=zhangjingnwpu, createdTime=Sat Aug 08 01:14:00 CST 2015, time=2015-08-08, status=1, ipAttribution=)]
    2016-01-12 medsic

    继续加油吧,

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=56324, encodeId=3f3156324ff, content=继续加油吧,, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:42:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56325, encodeId=2d635632589, content=继续加油吧,, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:42:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56326, encodeId=2780563260a, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:42:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56322, encodeId=77ae56322ab, content=还是不熟悉,哈哈…, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:41:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56323, encodeId=8626563234b, content=还是不熟悉,哈哈…, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:41:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1704905, encodeId=ca551e04905e7, content=<a href='/topic/show?id=71742062668' target=_blank style='color:#2F92EE;'>#专利申请#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20626, encryptionId=71742062668, topicName=专利申请)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e7a30885975, createdName=zhangjingnwpu, createdTime=Sat Aug 08 01:14:00 CST 2015, time=2015-08-08, status=1, ipAttribution=)]
    2016-01-12 medsic

    感谢分享~~

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=56324, encodeId=3f3156324ff, content=继续加油吧,, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:42:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56325, encodeId=2d635632589, content=继续加油吧,, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:42:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56326, encodeId=2780563260a, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:42:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56322, encodeId=77ae56322ab, content=还是不熟悉,哈哈…, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:41:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56323, encodeId=8626563234b, content=还是不熟悉,哈哈…, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:41:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1704905, encodeId=ca551e04905e7, content=<a href='/topic/show?id=71742062668' target=_blank style='color:#2F92EE;'>#专利申请#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20626, encryptionId=71742062668, topicName=专利申请)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e7a30885975, createdName=zhangjingnwpu, createdTime=Sat Aug 08 01:14:00 CST 2015, time=2015-08-08, status=1, ipAttribution=)]
    2016-01-12 medsic

    还是不熟悉,哈哈…

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=56324, encodeId=3f3156324ff, content=继续加油吧,, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:42:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56325, encodeId=2d635632589, content=继续加油吧,, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:42:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56326, encodeId=2780563260a, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:42:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56322, encodeId=77ae56322ab, content=还是不熟悉,哈哈…, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:41:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56323, encodeId=8626563234b, content=还是不熟悉,哈哈…, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:41:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1704905, encodeId=ca551e04905e7, content=<a href='/topic/show?id=71742062668' target=_blank style='color:#2F92EE;'>#专利申请#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20626, encryptionId=71742062668, topicName=专利申请)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e7a30885975, createdName=zhangjingnwpu, createdTime=Sat Aug 08 01:14:00 CST 2015, time=2015-08-08, status=1, ipAttribution=)]
    2016-01-12 medsic

    还是不熟悉,哈哈…

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=56324, encodeId=3f3156324ff, content=继续加油吧,, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:42:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56325, encodeId=2d635632589, content=继续加油吧,, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:42:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56326, encodeId=2780563260a, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:42:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56322, encodeId=77ae56322ab, content=还是不熟悉,哈哈…, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:41:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56323, encodeId=8626563234b, content=还是不熟悉,哈哈…, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:41:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1704905, encodeId=ca551e04905e7, content=<a href='/topic/show?id=71742062668' target=_blank style='color:#2F92EE;'>#专利申请#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20626, encryptionId=71742062668, topicName=专利申请)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e7a30885975, createdName=zhangjingnwpu, createdTime=Sat Aug 08 01:14:00 CST 2015, time=2015-08-08, status=1, ipAttribution=)]

相关资讯

专利申请须知:不授予专利权的情形

1.对违反国家法律、社会公德或者妨害公共利益的发明创造不授予专利权如,用于赌博的设备或工具;吸毒器具;伪造国家货币、票据、公文证件、印章、文物的设备等。2.科学发现:如,杠杆原理、外有引力定律。3.智力活动的规则和方法如,商业管理方法,图书分类法,汉字编码方法,仪器和设备的操作方法,游戏规则和方法,统计、会计和记账的方法,计算机的语言和计算规则,计算机程序本身,数学理论和换算方法等。4.疾病的诊断

专利申请须知:外观设计专利申请材料

外观设计专利申请需准备的资料:应提供:外观设计产品的六面视图、立体参考图及外观设计简要说明。六面视图:主视图,后视图,左视图,右视图,俯视图,仰视图。立体参考图:能同时展示三个面的视图。简要说明:1.外观设计产品的名称;2.外观设计产品的用途;3.外观设计产品的设计要点(形状、图案、色彩);4.最能表明设计要点的图片;5.省略视图说明,透明部分的说明,基本设计的指定。

各国及各行业的专利申请状况

各国及各行业的专利申请状况 (摘自国家知识产权局) 随着知识经济和经济全球化深入发展,知识产权日益成为发展的重要资源和竞争力的核心要素,截至2013年,我国发明专利申请量连续3年居世界首位,知识产权对经济转型发展的推动作用不断凸显,对创新驱动发展战略的支撑作用不断增强。 如下数据可显现出近年来国家及各行业对专利的重视程度: 2014年国内发明专利受理状况:

专利申请须知:技术交底书

什么是技术交底书?技术交底书是揭露一项专利申请的完整技术方案的文档,它包括特定的组成部分,由申请人起草,是整个专利流程的发起端。技术交底书的重要性其撰写的质量高低直接影响专利代理人对该专利申请的技术方案的理解与把握,是左右专利代理人起草符合专利法规定的申请文件的关键因素。如何撰写技术交底书发明/实用新型专利申请技术资料交底要求:1.名称:简明表述要保护的主题名称,名称应体现是产品或方法(一般25个

Baidu
map
Baidu
map
Baidu
map